Dialister-driven succinate accumulation is associated with disease activity and postoperative recurrence in Crohn's disease
Por:
Boronat-Toscano, A, Queipo-Ortuño, MI, Monfort-Ferré, D, Suau, R, Vaño-Segarra, I, Valldosera, G, Cepero, C, Astiarraga, B, Clua-Ferré, L, Plaza-Andrade, I, Aranega-Martín, L, Cabrinety, L, de Barbarà, CA, Castellano-Castillo, D, Moliné, A, Caro, A, Domènech, E, Sánchez-Herrero, JF, Benaiges-Fernandez, R, Fernández-Veledo, S, Vendrell, J, Ginés, I, Sumoy, L, Manyé, J, Menacho, M and Serena, C
Publicada:
7 dic 2025
Resumen:
BACKGROUND Succinate, a metabolite produced by both the gut microbiota and the host, has emerged as a key player in chronic inflammation. In patients with Crohn's disease (CD), increased succinate in the intestinal lumen correlates with both dysbiosis and greater disease activity. AIM To investigate circulating succinate as a biomarker of CD activity and its associations with gut microbiota, immune, and clinical features. METHODS This study with the prospective inclusion of patients with CD in remission, active CD, and non-inflammatory bowel disease controls matched by age, sex, and body mass index. Remission was defined as Harvey-Bradshaw index < 6, C-reactive protein < 0.4 mg/dL, fecal calprotectin < 250 mu g/g, and endoscopic activity index Simple Endoscopic Score for CD < 6. Faecal microbiota profiling was performed using 16S rRNA gene sequencing, and demographic, clinical, and treatment variables were recorded along with blood samples (C-reactive protein and succinate) and stool samples. RESULTS Succinate levels were significantly elevated in active CD patients compared to inactive patients and non-inflammatory bowel disease controls. These increases were associated with higher Harvey-Bradshaw Index scores, increased expression of the succinate receptor 1 in immune cells, and enrichment of the succinate-producing genus Prevotella and the pro-inflammatory phylum Proteobacteria. Conversely, succinate levels negatively correlated with Odoribacter, a known succinate consumer. Interestingly, Dialister, a slow succinate consumer, was enriched in both active and inactive CD patients and was associated with impaired circulating succinate clearance and increased disease activity as well as postoperative recurrence in a validation cohort. Functional microbial analyses revealed upregulation of fumarate reductase and succinate transporters, alongside reduced NADH dehydrogenase expression, indicating disrupted succinate metabolism. CONCLUSION These findings highlight succinate as a promising biomarker for CD activity and progression, suggesting that targeting succinate metabolism or key microbial taxa may offer novel therapeutic opportunities.
Filiaciones:
Boronat-Toscano, A:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Queipo-Ortuño, MI:
Virgen Victoria Hosp FIMABIS, Med Oncol Clin Management Unit, Biomed Res Lab, Campus Teatinos S N, Malaga 29010, Andalucia, Spain
Univ Malaga, Nutr Hosp Virgen Victoria, Unidad Gest Clin Endocrinol, Inst Invest Biomed Malaga, Malaga 29010, Spain
Monfort-Ferré, D:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
:
Inst Recerca Germans Trias i Pujol, Inflammatory Bowel Dis Res Grp, Badalona 08916, Catalonia, Spain
Vaño-Segarra, I:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Valldosera, G:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Cepero, C:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Astiarraga, B:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Inst Recerca Germans Trias i Pujol, Inflammatory Bowel Dis Res Grp, Badalona 08916, Catalonia, Spain
Plaza-Andrade, I:
Virgen Victoria Hosp FIMABIS, Med Oncol Clin Management Unit, Biomed Res Lab, Campus Teatinos S N, Malaga 29010, Andalucia, Spain
Aranega-Martín, L:
Virgen Victoria Hosp FIMABIS, Med Oncol Clin Management Unit, Biomed Res Lab, Campus Teatinos S N, Malaga 29010, Andalucia, Spain
Cabrinety, L:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
de Barbarà, CA:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Castellano-Castillo, D:
Virgen Victoria Hosp FIMABIS, Med Oncol Clin Management Unit, Biomed Res Lab, Campus Teatinos S N, Malaga 29010, Andalucia, Spain
Moliné, A:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Caro, A:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
:
Hosp Univ Germans Trias i Pujol, Dept Gastroenterol, Badalona 08916, Spain
Univ Autonoma Barcelona, Dept Med, Barcelona 08035, Spain
Inst Salud Carlos III, CIBER Enfermedades Hepat & Digest CIBERehd, Madrid, Spain
:
Inst Recerca Germans Trias i Pujol, Genom Alt Contingut & Bioinformat, Badalona 08916, Catalonia, Spain
Benaiges-Fernandez, R:
Inst Recerca Germans Trias i Pujol, Genom Alt Contingut & Bioinformat, Badalona 08916, Catalonia, Spain
Fernández-Veledo, S:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Inst Salud Carlos III, CIBER Diabet & Enfermedades Asociadas CIBERDEM, Madrid 28029, Spain
Vendrell, J:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Inst Salud Carlos III, CIBER Diabet & Enfermedades Asociadas CIBERDEM, Madrid 28029, Spain
Ginés, I:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Univ Rovira i Virgili, Dept Biochem & Biotecnol, Tarragona 43007, Catalonia, Spain
:
Inst Recerca Germans Trias i Pujol, Genom Alt Contingut & Bioinformat, Badalona 08916, Catalonia, Spain
Manyé, J:
Inst Recerca Germans Trias i Pujol, Inflammatory Bowel Dis Res Grp, Badalona 08916, Catalonia, Spain
Inst Salud Carlos III, CIBER Enfermedades Hepat & Digest CIBERehd, Madrid, Spain
Menacho, M:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Serena, C:
Hosp Univ Joan XXIII, Inst Invest Sanit Pere Virgili, C Escorxador S-N, Tarragona 43007, Catalonia, Spain
Inst Salud Carlos III, CIBER Enfermedades Hepat & Digest CIBERehd, Madrid, Spain
Univ Rovira i Virgili, Dept Biochem & Biotecnol, Tarragona 43007, Catalonia, Spain
Green Submitted, Green Accepted, hybrid
|